Blood Pressure Variability in Acute Ischemic Stroke (PREVISE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01915862|
Recruitment Status : Completed
First Posted : August 5, 2013
Last Update Posted : April 5, 2019
|Condition or disease|
All consecutive patients admitted with acute (within 24 hours after stroke onset) ischemic stroke in three University Hospital of Northern and Central Greece will be included.
Blood pressure measurements are being obtained with ambulatory 24-hour BP monitoring (ABPM) every 20 minutes within 24 hours of admission using automated oscillometric device (TM2430, A&D Company Ltd) during day-time (7:00-22:59) and night-time (23:00-6:59).
Several clinical, laboratory and imaging parameters are prospectively registered. Also, patients' medical history, previous medical treatment and cardiovascular risk factors are registered.
Functional outcome is assessed by the modified Rankin Scale score at 3 months. Also, stroke recurrence and cardiovascular and all-cause mortality will be assessed.
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||353 participants|
|Target Follow-Up Duration:||3 Months|
|Official Title:||Comparison of Blood Pressure Variability Indices and Ambulatory Arterial Stiffness Index as Prognostic Indicators in the Medium Term Outcome of Acute Ischemic Stroke|
|Study Start Date :||August 2013|
|Actual Primary Completion Date :||May 2018|
|Actual Study Completion Date :||December 2018|
- Modified Rankin Scale Score (mRS) [ Time Frame: Three months (90 days) ]
- No symptoms at all (0)
- No significant disability despite symptoms; able to carry out all usual duties and activities (1)
- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance (2)
- Moderate disability; requiring some help, but able to walk without assistance (3)
- Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance (4)
- Severe disability; bedridden, incontinent and requiring constant nursing care and attention(5)
- Dead (6)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01915862
|Second Department of Internal Medicine, Medical School, University of Ioannina, University Hospital of Ioannina|
|Ioannina, Greece, 45110|
|Department of Medicine, Medical School, University of Thessaly, University Hospital of Larissa|
|Larissa, Greece, 41110|
|First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital|
|Thessaloniki, Greece, 54636|
|Study Director:||Apostolos I. Hatzitolios, MD, PhD||Aristotle University of Thessaloniki, AHEPA University Hospital|